Acadia Pharmaceuticals (ACAD) Interest & Investment Income (2010 - 2026)
Acadia Pharmaceuticals' quarterly Interest & Investment Income came in at $8.1 million in Q1 2026, up 1.95% year-on-year from $7.9 million in Q1 2025, and down 3.32% quarter-over-quarter from $8.3 million in Q4 2025.
Acadia Pharmaceuticals has reported Interest & Investment Income for 17 years, with the latest figure at $8.1 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 1.95% year-over-year to $8.1 million; the trailing twelve-month figure through Mar 2026 stood at $31.9 million (up 14.44% YoY), and the FY2025 full-year result was $31.7 million, up 24.61% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $8.1 million, down from $8.3 million in the prior quarter.
- The five-year high for Interest & Investment Income was $8.3 million in Q4 2025, with the low at $105000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $5.2 million, with a median of $5.5 million recorded in 2024.
- Year-over-year, Interest & Investment Income slumped 47.5% in 2022 and jumped 3519.05% in 2023.
- Tracing ACAD's Interest & Investment Income over 5 years: stood at $3.6 million in 2022, then surged by 31.1% to $4.8 million in 2023, then surged by 47.24% to $7.0 million in 2024, then climbed by 18.91% to $8.3 million in 2025, then declined by 3.32% to $8.1 million in 2026.
- The last three Interest & Investment Income figures came in at $8.1 million (Q1 2026), $8.3 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | 8.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.06 Mn |
| Dec 31, 2025 | 8.33 Mn |
| Sep 30, 2025 | 8.25 Mn |
| Jun 30, 2025 | 7.24 Mn |
| Mar 31, 2025 | 7.90 Mn |
| Dec 31, 2024 | 7.01 Mn |
| Sep 30, 2024 | 6.59 Mn |
| Jun 30, 2024 | 6.36 Mn |
| Mar 31, 2024 | 5.51 Mn |
| Dec 31, 2023 | 4.76 Mn |
| Sep 30, 2023 | 4.13 Mn |
| Jun 30, 2023 | 4.55 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Sep 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | 580,000.00 |
| Mar 31, 2022 | 105,000.00 |
| Dec 31, 2021 | 129,000.00 |
| Sep 30, 2021 | 129,000.00 |
| Jun 30, 2021 | 133,000.00 |
| Mar 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 554,000.00 |
| Sep 30, 2020 | 1.24 Mn |
| Jun 30, 2020 | 1.83 Mn |
| Mar 31, 2020 | 2.99 Mn |
| Dec 31, 2019 | 3.27 Mn |
| Sep 30, 2019 | 2.43 Mn |
| Jun 30, 2019 | 2.53 Mn |
| Mar 31, 2019 | 2.93 Mn |
| Dec 31, 2018 | 1.67 Mn |
| Sep 30, 2018 | 1.23 Mn |
| Jun 30, 2018 | 1.28 Mn |
| Mar 31, 2018 | 1.17 Mn |
| Dec 31, 2017 | 1.11 Mn |
| Sep 30, 2017 | 1.06 Mn |
| Jun 30, 2017 | 993,000.00 |
| Mar 31, 2017 | 963,000.00 |
| Dec 31, 2016 | 876,000.00 |
| Sep 30, 2016 | 786,000.00 |
| Jun 30, 2016 | 601,000.00 |
| Mar 31, 2016 | 500,000.00 |
| Dec 31, 2015 | 111,000.00 |
| Sep 30, 2015 | 92,000.00 |
| Jun 30, 2015 | 119,000.00 |
| Mar 31, 2015 | 177,000.00 |
| Dec 31, 2014 | 188,000.00 |
| Sep 30, 2014 | 208,000.00 |
| Jun 30, 2014 | 228,000.00 |
| Mar 31, 2014 | 130,000.00 |
| Dec 31, 2013 | 115,000.00 |
| Sep 30, 2013 | 116,000.00 |
| Jun 30, 2013 | 76,000.00 |
| Mar 31, 2013 | 41,000.00 |
| Dec 31, 2012 | 9,000.00 |
| Sep 30, 2012 | 5,000.00 |
| Jun 30, 2012 | 10,000.00 |
| Mar 31, 2012 | 13,000.00 |
| Dec 31, 2011 | 14,000.00 |
| Sep 30, 2011 | 17,000.00 |
| Jun 30, 2011 | 28,000.00 |
| Mar 31, 2011 | 28,000.00 |
| Dec 31, 2010 | 12,000.00 |
| Sep 30, 2010 | 15,000.00 |